Home

Home

 

 … Sofinnova Partners sells portfolio company Ethical Oncology Science (EOS) to Clovis Oncology for $200 million upfront and up to an additional $220 million in milestones [+]

 

Sofinnova Partners is an independent venture capital firm based in Paris. Over the past 40 years, the firm has financed and accompanied almost 500 companies.

We invest in start-ups, early-stage companies, corporate spin-offs and occasionally turnaround situations. We invest in Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. We sit on the boards of our portfolio companies, and play an active role from the formation phase alongside entrepreneurs. We invest throughout Europe from our headquarters in Paris with a portion of investments made in the rest of the world.

 

Highlighted Success Stories

novexel movetis preglem_4-9-2 EOS Omthera_Logo_RGB actelion
 

Featured Investments

obseva_web reflexion_web CelluComp_web shockwave_web MedDay greenbiologics_web


View the complete portfolio